Health · Pharma & Biotech · 2 hrs ago
Bemotrizinol sunscreens reach US stores after FDA approval
Bemotrizinol sunscreens are reaching US store shelves after the FDA approved the ingredient in June.
The chemical, also called BEMT, has been used in Europe and other parts of the world.
It protects against both UVA and UVB rays, which can damage skin and contribute to skin cancer.
Before BEMT, US manufacturers had to combine multiple chemical ingredients to get that kind of protection; mineral sunscreens also provide it but can leave white streaks.
Studies found very little BEMT was absorbed through the skin, and the FDA review found no irritation or allergic reactions in the studies described.
The new option could suit people who avoid mineral formulas because of their appearance or feel, and products from Neutrogena and other makers are now becoming available.
The first US sunscreens containing bemotrizinol are reaching store shelves after the FDA approved the ingredient in June.
Bemotrizinol offers broad-spectrum protection against UVA and UVB rays.
Dermatologists say it may provide an option for people who dislike the white streaking or texture of some mineral sunscreens.
Studies reviewed by the FDA found nearly undetectable skin absorption and no irritation or allergic reactions in people using it daily for up to three weeks.
- Who
- US sunscreen shoppers, including people seeking broad-spectrum protection without white streaking.
- What
- Sunscreens containing bemotrizinol are reaching US stores after FDA approval.
- When
- The FDA approved bemotrizinol in June; the first products were reaching stores by October 14, 2026.
- Where
- The United States.
- Why
- Bemotrizinol offers protection against both UVA and UVB rays and may address cosmetic drawbacks of some other sunscreens.
This story does not have two clearly opposing sides.
The FDA approved bemotrizinol.
The first US sunscreens containing bemotrizinol were reaching store shelves.
- Ingredient
- Bemotrizinol, also called BEMT
- FDA approval
- June 2026
- Products
- Formulas from Neutrogena and other manufacturers
- Safety review
- Studies in more than 500 patients
- Use studied
- Daily use for up to three weeks
What people are saying
It’s not a brand-new ingredient that you’re going to be the first person to try
This ingredient provides a solution for what is currently a big gap with respect to providing strong UVA protection